Phagelux has developed a cocktail of bacteriophages (bacterial viruses) that treat infections with bacteria resistant to antibiotics. During the curse of treatment, bacteria may become resistant to bacteriophages included in the cocktail. This project aims at determing the bacteria surface markers on which bacteriophages can bind and start their therapeutic function. This will help Phagelux […]
Read More